NEW HAVEN, Conn., Feb. 25, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence ...
The lack of consensus or accepted definition for light sedation presents challenges to critical care practitioners seeking to follow guidelines related to pain, agitation and delirium. Comfort and ...
Intravenous anesthesia and sedation techniques have undergone significant evolution in recent years, driven by the need for rapid onset, improved safety profiles, and enhanced recovery characteristics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback